Effect of Ifetroban, a Thromboxane a2Receptor Antagonist, in Stroke-Prone Spontaneously Hypertensive Rats
Data up to Jan 2025
Total Citations Per Year
Abstract
References (30)
PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENT
1951 • 319,299 citations
Statistical Methods for Survival Data Analysis
1981 • 758 citations
Low dose aspirin and inhibition of thromboxane B2 production in healthy subjects
1980 • 642 citations
Establishment of the strokeprone spontaneously hypertensive rat (SHR)
1972 • 606 citations
Swedish Aspirin Low-dose Trial (SALT) of 75 mg aspirin as secondary prophylaxis after cerebrovascular ischaemic events
1991 • 525 citations
Pathogenetic similarity of strokes in stroke-prone spontaneously hypertensive rats and humans.
1976 • 372 citations
Regional Myocardial Blood Flow in Lambs with Concentric Right Ventricular Hypertrophy
1974 • 255 citations
A New Method for Continuous Chronic Measurement and Recording of Blood Pressure, Heart Rate and Activity in the Rat Via Radio-telemetry
1991 • 251 citations
Effects of low-to-high doses of aspirin on platelet aggregability and metabolites of thromboxane A2 and prostacyclin.
1992 • 210 citations
Genetic predisposition to stroke in spontaneously hypertensive rats
1976 • 169 citations
Enalapril prevents stroke and kidney dysfunction in salt-loaded stroke-prone spontaneously hypertensive rats.
1989 • 143 citations
Possible role of nutritional factors in the incidence of cerebral lesions in stroke-prone spontaneously hypertensive rats.
1984 • 114 citations
Telemetric Monitoring of Cardiovascular Parameters in Conscious Spontaneously Hypertensive Rats
1993 • 101 citations
Treatment of ischaemic stroke with prostacyclin.
1983 • 90 citations
Role of prostaglandin H2-thromboxane A2 in responses of cerebral arterioles during chronic hypertension
1992 • 64 citations
Role of prostanoids in renin-dependent and renin-independent hypertension.
1991 • 63 citations
Pharmacological profile of BMS 180,291: a potent, long-acting, orally active thromboxane A2/prostaglandin endoperoxide receptor antagonist.
1993 • 59 citations
Role of pressor prostanoids in rats with angiotensin II-salt-induced hypertension.
1988 • 52 citations
Dissociation of endothelial cell dysfunction and blood pressure in SHR
1995 • 42 citations
Thromboxane Receptor Antagonist BMS-180291, but Not Aspirin, Reduces the Severity of Pacing-Induced Ischemia in Dogs
1994 • 28 citations
Thromboxane A2 in severe hypertension and stroke in stroke-prone spontaneously hypertensive rats.
1988 • 26 citations
Thromboxane receptor antagonist BMS-180291: A new pre-clinical lead
1992 • 22 citations
Single studies and overview analyses: is aspirin of value in cerebral ischemia?
1987 • 21 citations
Antiplatelet activity of the long-acting thromboxane receptor antagonist BMS 180,291 in monkeys
1992 • 17 citations
Role of thromboxane A2 in the hypotensive effect of captopril in essential hypertension.
1988 • 16 citations
Thromboxane A2 receptor antagonism and synthase inhibition in essential hypertension.
1993 • 15 citations
The Effect of the Thromboxane A2/Prostaglandin Endoperoxide Receptor Antagonist SQ 30,741 on Myocardial Infarct Size and Blood Flow During Myocardial Ischemia and Reperfusion
1988 • 15 citations
Myocardial Salvage Efficacy of the Thromboxane Receptor Antagonist Ifetroban in Ferrets and Dogs
1994 • 10 citations
Effects of prostaglandin inhibitors on the onset of proteinuria and stroke in stroke-prone spontaneously hypertensive rats.
1981 • 8 citations
Ifetroban Sodium < USAN >
1994 • 6 citations